🧪 IN-ARMOR reaches a new milestone in nanocarrier development!
As part of WP3, led by @cinbio_uvigo , the project has successfully completed the optimisation and comprehensive characterisation of its mesoporous silica nanoparticle (MSNP)-based nanocarriers.
#EUFunded #HaDEA #AMR
New milestone achieved!
The consortium has completed the advanced characterisation of its selected lead compounds for host-directed therapies (HDTs) against antimicrobial resistance.
🔗 inarmor-project.eu/
#EUFunded #HaDEA #INARMOR #HorizonEurope #HostDirectedTherapy
🚨 IN-ARMOR partners meet in Madrid! 🇪🇺
On 16–17 September, we hold our 4th Consortium Meeting & 14th Management Board Meeting, hosted by @SaludMadrid.
🤝 2 days to review progress, strengthen collaboration and plan the next steps in the fight against #AMR.
#EUFunded #HaDEA
The IN-ARMOR consortium successfully held its 13th Management Board Meeting (#MBM13).
With our 2nd Reporting Period officially closed, we are now fully focused on preparing for our 2nd Project Review with the @EU_Commission this July. 👇










